Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis

Objectives: The impressive improvements of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) function by elexacaftor/tezacaftor/ivacaftor (ETI) result in changes in the detection frequencies of Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA). We assessed determinants of the...

詳細記述

書誌詳細

主要な著者:	Anna-Maria Dittrich, Sarah Sieber, Lutz Naehrlich, Manuel Burkhart, Sylvia Hafkemeyer, Burkhard Tümmler
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2024-02-01
シリーズ:	International Journal of Infectious Diseases
主題:	Cystic fibrosis Pseudomonas aeruginosa Staphylococcus aureus CFTR modulator Elexacaftor, tezacaftor, ivacaftor
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S1201971223007749
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!